Sarepta Therapeutics, Inc. SRPT
NASDAQ · United States · Health Technology
$17.57-0.65 (-3.57%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.05 | 0.22 | -123.0% | $401.25M | +9.5% | +2.4%$16.39→$16.78 |
| Q1 2026 | 2026-05-06 | 3.16 | 1.05 | +201.0% | — | — | -4.5%$21.79→$20.80 |
| Q4 2025 | 2026-02-25 | -3.58 | -0.77 | -364.9% | — | — | -7.4%$18.84→$17.45 |
| Q3 2025 | 2025-11-03 | -0.13 | -0.37 | +64.9% | — | — | -32.5%$24.01→$16.20 |
| Q2 2025 | 2025-08-06 | 2.02 | 1.16 | +74.1% | — | — | — |
| Q1 2025 | 2025-05-06 | -3.42 | -0.65 | -426.2% | — | — | — |
| Q4 2024 | 2025-02-26 | 1.90 | 2.06 | -7.8% | — | — | — |
| Q3 2024 | 2024-11-06 | 0.62 | 0.37 | +67.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.